153 related articles for article (PubMed ID: 21729005)
21. Interleukin-1beta up-regulation of Smad7 via NF-kappaB activation in human chondrocytes.
Baugé C; Attia J; Leclercq S; Pujol JP; Galéra P; Boumédiene K
Arthritis Rheum; 2008 Jan; 58(1):221-6. PubMed ID: 18163503
[TBL] [Abstract][Full Text] [Related]
22. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
23. TGFbeta1 induces vasculogenesis and inhibits angiogenic sprouting in an embryonic stem cell differentiation model: respective contribution of ALK1 and ALK5.
Mallet C; Vittet D; Feige JJ; Bailly S
Stem Cells; 2006 Nov; 24(11):2420-7. PubMed ID: 17071858
[TBL] [Abstract][Full Text] [Related]
24. Hepatocyte 'priming' and increase in transforming growth factor-beta1 mRNA expression are delayed in hypothyroid versus euthyroid rats during liver regeneration.
Moro L; Perlino E; Marra E; Greco M
Int J Mol Med; 2006 Jun; 17(6):1063-8. PubMed ID: 16685417
[TBL] [Abstract][Full Text] [Related]
25. Microsatellite unstable colorectal cancer cell lines with truncating TGFbetaRII mutations remain sensitive to endogenous TGFbeta.
Baker K; Raut P; Jass JR
J Pathol; 2007 Nov; 213(3):257-65. PubMed ID: 17893910
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor-beta1 upregulates myostatin expression in mouse C2C12 myoblasts.
Budasz-Rwiderska M; Jank M; Motyl T
J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():195-214. PubMed ID: 16077203
[TBL] [Abstract][Full Text] [Related]
27. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.
Chen A
Biochem J; 2002 Dec; 368(Pt 3):683-93. PubMed ID: 12223100
[TBL] [Abstract][Full Text] [Related]
28. The effect of growth factor supplementation on corneal stromal cell phenotype in vitro using a serum-free media.
Lynch AP; O'Sullivan F; Ahearne M
Exp Eye Res; 2016 Oct; 151():26-37. PubMed ID: 27456135
[TBL] [Abstract][Full Text] [Related]
29. Construction of recombinant adenovirus co-expression vector carrying the human transforming growth factor-beta1 and vascular endothelial growth factor genes and its effect on anterior cruciate ligament fibroblasts.
Wei XL; Lin L; Hou Y; Fu X; Zhang JY; Mao ZB; Yu CL
Chin Med J (Engl); 2008 Aug; 121(15):1426-32. PubMed ID: 18959121
[TBL] [Abstract][Full Text] [Related]
30. Desmoid and fibroma tumors differently respond to TGFbeta(1) stimulus and ECM macromolecule accumulation.
Locci P; Balducci C; Lilli C; Marinucci L; Becchetti E; Dolci C; Calastrini C; Lumare E; Stabellini G
Biomed Pharmacother; 2007; 61(2-3):131-6. PubMed ID: 17145161
[TBL] [Abstract][Full Text] [Related]
31. Vectorial TGFbeta signaling in polarized intestinal epithelial cells.
Yakovich AJ; Huang Q; Du J; Jiang B; Barnard JA
J Cell Physiol; 2010 Aug; 224(2):398-404. PubMed ID: 20432436
[TBL] [Abstract][Full Text] [Related]
32. Fibroblast growth factor reversal of the corneal myofibroblast phenotype.
Maltseva O; Folger P; Zekaria D; Petridou S; Masur SK
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2490-5. PubMed ID: 11581188
[TBL] [Abstract][Full Text] [Related]
33. Effects of interferon-gamma on human subconjunctival fibroblasts in the presence of TGFbeta1: reversal of TGFbeta-stimulated collagen production.
Yamanaka O; Saika S; Okada Y; Ooshima A; Ohnishi Y
Graefes Arch Clin Exp Ophthalmol; 2003 Feb; 241(2):116-24. PubMed ID: 12605266
[TBL] [Abstract][Full Text] [Related]
34. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.
Kubo M; Ihn H; Yamane K; Tamaki K
Br J Dermatol; 2006 May; 154(5):919-25. PubMed ID: 16634896
[TBL] [Abstract][Full Text] [Related]
35. The role of miR‑370 in fibrosis after myocardial infarction.
Yuan H; Gao J
Mol Med Rep; 2017 May; 15(5):3041-3047. PubMed ID: 28350072
[TBL] [Abstract][Full Text] [Related]
36. Effect of cAMP on TGFbeta1-induced corneal keratocyte-myofibroblast transformation.
Xing D; Bonanno JA
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):626-33. PubMed ID: 18936144
[TBL] [Abstract][Full Text] [Related]
37. Latent transforming growth factor binding protein 4 regulates transforming growth factor beta receptor stability.
Su CT; Huang JW; Chiang CK; Lawrence EC; Levine KL; Dabovic B; Jung C; Davis EC; Madan-Khetarpal S; Urban Z
Hum Mol Genet; 2015 Jul; 24(14):4024-36. PubMed ID: 25882708
[TBL] [Abstract][Full Text] [Related]
38. Endogenous transforming growth factor-beta promotes quiescence of primary microglia in vitro.
Spittau B; Wullkopf L; Zhou X; Rilka J; Pfeifer D; Krieglstein K
Glia; 2013 Feb; 61(2):287-300. PubMed ID: 23065670
[TBL] [Abstract][Full Text] [Related]
39. Concentration-dependent effects of transforming growth factor β1 on corneal wound healing.
Wang L; Ko CY; Meyers EE; Pedroja BS; Pelaez N; Bernstein AM
Mol Vis; 2011; 17():2835-46. PubMed ID: 22128231
[TBL] [Abstract][Full Text] [Related]
40. Growth factor regulation of corneal keratocyte differentiation and migration in compressed collagen matrices.
Kim A; Lakshman N; Karamichos D; Petroll WM
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):864-75. PubMed ID: 19815729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
